MRKR Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Marker Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.2 USD -0.83% Market Closed

Market Cap: $20m

	Marker Therapeutics Inc NASDAQ:MRKR	US
	Oxford BioMedica PLC LSE:OXB	UK
	Daito Trust Construction Co Ltd TSE:1878	JP
	Modern Internasional Tbk PT IDX:MDRN	ID
	Emperador Inc SGX:EMI	PH
	Boadicea Resources Ltd ASX:BOA	AU
	Fermiere du Casino Municipal Cannes SA PAR:FCMC	FR
	Lufax Holding Ltd NYSE:LU	CN
	I-nexus Global PLC LSE:INX	UK
S	Symphony Communication PCL SET:SYMC	TH

Profitability Summary

Marker Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-351%

Negative 3Y Average Operating Margin

-291%

Declining Operating Margin

-288% > -351%

Negative Net Margin

-343%

Negative 3Y Average Net Margin

-235%

Declining Net Margin

-210% > -343%

Negative Free Cash Flow Margin

-339%

Negative 3Y Average Free Cash Flow Margin

-299%

Free Cash Flow Margin is Increasing

-427% > -339%

Negative ROE

-69%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-454%

Declining ROIC

-144% > -894%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.